Treatment with 4-IPP (inhibitor of MIF or D-DT) showed the potential to improve radiotherapy by inhibiting the stemness and intracellular signaling pathways and inducing apoptosis in vitro and in vivo glioma models [140]. The gene discussed is MIF; the disease is central nervous system cancer.